IN Brief:
- Plantible has raised $35 million through a USDA-backed loan and additional equity.
- Up to 50 commercial greenhouses will lift annual Rubi Protein capacity above 1,000 tonnes.
- Commercial performance depends on scaling cultivation, extraction, drying, quality control, and customer qualification together.
A $35 million financing package will allow Plantible Foods to increase production of its Lemna-derived Rubi Protein more than fivefold at its Ranchito facility in Eldorado, Texas.
The package combines $25 million of debt financing through the USDA OneRD Business & Industry programme with a $10 million equity investment from RA Capital and existing investors. Plantible plans to build up to 50 additional commercial greenhouses and lift annual production capacity above 1,000 metric tonnes.
Tony Martens, co-founder and chief executive of Plantible Foods, said: “We now have the means to build capacity and meet the industry’s demand.” The company has not disclosed a construction timetable, employment figure, customer commitments, or the number of greenhouses included in the first phase.
The expansion follows regulatory progress in February, when the US Food and Drug Administration issued a “no questions” letter in response to Plantible’s conclusion that isolated Rubi Protein is generally recognised as safe for its intended uses. That decision supports commercial adoption, but customers still need to complete their own formulation, labelling, process, and shelf-life assessments.
Cultivation and extraction must scale together
Rubi Protein is derived from Lemna, also known as water lentils, grown in enclosed aquatic production systems. Plantible harvests the crop and processes it into an ingredient that the company says contains approximately 85% protein, all nine essential amino acids, vitamin B12, and no known allergens.
The ingredient is positioned for bakery, beverages, dairy alternatives, nutrition products, snacks, and meat alternatives, with binding, emulsification, foaming, solubility, and texture among its claimed functions. Those properties move the product beyond straightforward protein fortification because it must continue performing through mixing, heating, cooling, storage, and final preparation.
Adding greenhouse area addresses the biological front end, but the downstream process must expand at a compatible rate. More Lemna requires additional harvesting, dewatering, milling, filtration, drying, cleaning, powder handling, testing, and storage capacity, otherwise one of those stages becomes the new production constraint.
Controlled cultivation can reduce exposure to seasonal variation and extreme weather, yet biological systems still require close management of water quality, nutrient dosing, temperature, pH, crop health, contamination, and harvesting frequency. Replicating stable output across a larger greenhouse estate will depend on automation, maintenance, data quality, and trained operators.
The company describes the expansion as modular, allowing capacity to be added in stages. That approach can limit the risk of building the entire estate ahead of demand, although each module still has to integrate with common utilities, processing equipment, laboratories, and finished-product logistics.
More capacity shifts the risk downstream
Plantible says the financing will support an existing customer pipeline and entry into new markets. The announcement identifies ICL Food Specialties as a customer using Rubi Protein in ingredient formulations, but does not disclose contracted volumes or the proportion of the enlarged capacity covered by current agreements.
Utilisation is therefore the central commercial test. A fivefold increase can improve unit economics if qualification and repeat ordering rise with it; if adoption takes longer, the business will carry greenhouse, processing, labour, and financing costs before the additional tonnes generate sufficient revenue.
The USDA-backed structure improves access to long-term capital but does not remove operating risk. Crop performance, extraction yield, drying efficiency, batch consistency, and customer acceptance must all develop together, while any disruption at the cultivation stage can affect downstream plant loading.
Alternative-protein manufacturing is also expanding through several technical routes. Recent investment in dry-extruded pea and fava proteins showed a model based on established crops and extrusion, while Plantible is pursuing a more vertically integrated system that combines controlled cultivation with extraction.
Vertical integration provides traceability and allows the crop and process to be developed together, but it places greenhouse engineering, water management, food processing, quality control, and ingredient applications inside one operating model. Weakness in any stage can limit the value of the others.
Commercial customers will expect specification consistency as well as regulatory clearance. Protein concentration, colour, flavour, particle size, microbiological status, solubility, and functional performance must remain within agreed limits across larger batches and longer production campaigns.
The expansion gives Plantible a physical route towards meaningful commercial scale. The next evidence will come from greenhouse completion, stable output above current capacity, and named applications that convert the additional protein into recurring food production rather than unused availability.
